Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure

References

• Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Card Fail. 2007;13:422–430.
   PubMed Web of Science ®Google Scholar
• Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, et al. APPROACH Investigators. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44:1587–92.
   PubMed Web of Science ®Google Scholar
• Klein L, Massie BM, Leimberger JD, O’Connor CM, Piña IL, Adams KF Jr, et al. OPTIME-CHF Investigators. Heart failure predicts postdischarge survival: Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF). Circ Heart Fail. 2008;1: 25–33.
   Google Scholar
• Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, Di Capua P, et al. Renal impairment and outcomes in heart failure systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987–96.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract. 2008;109:c182–7.
   PubMed Web of Science ®Google Scholar
• Bagshaw S, Cruz DN, Aspromonte N, Daliento L, Ronco F, Sheinfeld G, et al. For the acute dialysis quality initiative (ADQI) consensus group. Epidemiology of cardio-renal syndromes: Workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010;25:1406–16.
   Google Scholar
• Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2008;52: 425–33.
   PubMed Web of Science ®Google Scholar
• Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J. 2009;30:1229–36.
   PubMed Web of Science ®Google Scholar
• Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71:967–70.
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; for the NGAL Meta-analysis investigator group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012–24
   PubMed Web of Science ®Google Scholar
• Alvelos M, Pimentel R, Pinho E, Gomes A, Lourenço P, Teles MJ, et al. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol. 2011;6:476–81.
   PubMed Web of Science ®Google Scholar
• Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail. 2010;16:49–54.
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, et al. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL evaluation along B-type natriuretic peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011;13:846–51.
   PubMed Web of Science ®Google Scholar
• Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardio-renal syndrome. J Am Coll Cardiol. 2008;52:1527–9.
   PubMed Web of Science ®Google Scholar
• Schiller NB, Shah PN, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989; 2:358–67.
   PubMed Web of Science ®Google Scholar
• Damman K, Van Veldhhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010;96:1297–302.
   PubMed Web of Science ®Google Scholar
• Alvelos M, Lourenco P, Dias C, Amorim M, Rema J, Leite AB, et al. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure. Int J Cardiol. 2013;165:51–5.
   PubMed Web of Science ®Google Scholar
• Maisel AS, Katz N, Hillege HL, Shaw A, Zanco P, Bellomo R, et al. Acute dialysis quality initiative consensus group. Biomarkers in kidney and heart disease. Neprol Dial Transplant. 2011;26:62–74.
   Google Scholar
• Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, Arenja N, et al. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012;16:R2.
   Google Scholar
• Liang V, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008;36:S75–88.
   PubMedGoogle Scholar
• Palazzuoli A, Nuti R. Heart failure: Pathophysiology and clinical picture. Contrib Nephrol. 2010;164:1–10.
   Google Scholar
• Metra M, Dei Cas L, Bristow MR. The pathophysiology of acute heart failure—it is a lot about fluid accumulation. Am Heart J. 2008;155:1–5.
   Google Scholar
• Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10:165–9.
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, Mitsnefes M, Kelly C, Ruff S, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231–8.
   PubMed Web of Science ®Google Scholar
• Kazory A. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol. 2010;106:694–700.
   PubMed Web of Science ®Google Scholar
• Damman K, Masson S, Hillege HL, Maggioni AP, Voor AA, Opasich C, et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J. 2011;32:2705–12.
   PubMed Web of Science ®Google Scholar
• Shrestha K, Borowski AG, Troughton RW, Thomas JD, Klein AL, Tang WH. Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase associated lipocalin levels than myocardial dysfunction in systolic heart failure. J Cardiac Fail. 2011;17:472–8.
   PubMed Web of Science ®Google Scholar
• Dupont M, Shrestha A, Singh D, Awad A, Kovach C, Scarcipino M, et al. Lack of significant renal tubular damage injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail. 2012;14 597–604.
   Google Scholar
• Testani JM, Coca SG, Shannon RP, Kimmel SE, Cappola TP. Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: Analysis of three randomized controlled trials. Eur J Heart Fail. 2011;13:1224–30.
   Google Scholar
• Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. The role of kidney in heart failure. Eur Heart J. 2012;33: 2135–43.
   PubMed Web of Science ®Google Scholar